Merck
  • Inicio
  • Resultados de la búsqueda
  • Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway.

Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway.

Oncology reports (2020-01-03)
Zhi Teng, Shijuan Xu, Qin Lei
RESUMEN

Acute lymphoblastic leukemia (ALL) is a malignant hematological disease. Tanshinone IIA (Tan IIA) has antitumor activity in vitro and in vivo. The aim of the present study was to investigate the effects of Tan IIA in combination with imatinib (IM) on the proliferation, apoptosis, migration and invasion of acute T lymphocytic leukemia TIB‑152 cells in vivo and in vitro, and analyze the potential underlying mechanism. Tan IIA and IM, alone and in combination, significantly inhibited proliferation, migration and invasion of TIB‑152 cells, and promoted apoptosis; the effect of co‑treatment with Tan IIA plus IM was enhanced. IGF‑1 promoted the proliferation, migration and invasion of TIB‑152 cells and inhibited apoptosis, while Tan IIA treatment significantly reversed these effects. In vivo experiments demonstrated that treatment with Tan IIA and IM, alone or in combination, significantly inhibited tumor growth in TIB‑152 xenograft mice; the growth inhibition of Tan IIA plus IM was the strongest observed. Western blot analysis revealed that the combination of Tan IIA and IM resulted in significantly lower levels of p‑PI3K, p‑AKT and p‑mTOR in cells and tissues compared with the IM and Tan alone treatment groups. In addition, the combination of Tan IIA and IM significantly decreased the levels of Ki67, cleaved caspase‑3, VEGF and MMP‑9 in cells and tissues, and the level of caspase‑3 was significantly increased. Taken together, the results revealed that Tan IIA enhanced the inhibitory effect of imatinib on TIB‑152 cell proliferation, migration and invasion, and induced apoptosis, which may be associated with inhibition of the PI3K/AKT/mTOR signaling pathway.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anti-AKT antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Monoclonal Anti-VEGF antibody produced in mouse, clone 3F7, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-Ki67 Antibody, clone 1O15, ZooMAb® Rabbit Monoclonal, recombinant, expressed in HEK 293 cells
Sigma-Aldrich
Monoclonal Anti-Mmp9 antibody produced in mouse, clone S51-82, purified immunoglobulin
Sigma-Aldrich
Monoclonal Anti-PIK3CA antibody produced in mouse, clone 4F3, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
(Tyr[SO3H]27)Cholecystokinin fragment 26-33 Amide, ≥97% (HPLC), powder
Sigma-Aldrich
Anti-MMP-9 antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-PI3-kinase p85-α antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-Caspase 3 Antibody, large subunit & proform, clone 4-1-18, clone 4-1-18, Chemicon®, from mouse
Sigma-Aldrich
Monoclonal Anti-MKI67 antibody produced in mouse, clone 4A1, ascites fluid